Filing Details
- Accession Number:
- 0001179110-18-002111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-14 18:11:08
- Reporting Period:
- 2018-02-12
- Accepted Time:
- 2018-02-14 18:11:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1294284 | Venkataraman Ganesh Kaundinya | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Coo & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-12 | 10,103 | $7.41 | 501,031 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-12 | 341 | $16.20 | 500,690 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-14 | 4,645 | $15.16 | 496,045 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2018-02-12 | 50,000 | $0.00 | 50,000 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-02-12 | 10,103 | $7.41 | 10,103 | $7.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | No | 4 | A | Direct | ||
| 0 | 2012-02-22 | 2018-02-22 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
Billionaire Hedge Funds
